Key facts
- It has raised $51.5M across 1 recorded rounds; the latest was Later Stage VC (Series C) ($30.0M) in Feb 2021.
- Notable investors include Google for Startups, Qualcomm Ventures, Microsoft for Startups, Octopus Ventures, OurCrowd — 24 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Medisafe
Funding rounds
1 roundsAbout Medisafe
Developer of a medication management platform designed to address significant causes of non-adherence to medication schedules. The company's platform facilitates patient-centric cloud-synced medication management addressing major causes of non-adherence and has features to send alerts to users and caretakers at medication time, enabling the medical community and patients to stay organized, informed, and on a budget.
- Industry
- Other Healthcare Technology Systems
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2012
- Employees
- 110
- Website
- medisafe.com/
- Ownership
- Privately Held (backing)
Medisafe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medisafe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medisafe in its N-PORT filings yet. We sweep new filings monthly.